Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Vitiligo | D014820 | EFO_0004208 | L80 | — | 1 | — | — | — | 1 |
Drug common name | Cerdulatinib |
INN | cerdulatinib |
Description | Cerdulatinib is a small molecule SYK/JAK kinase inhibitor in development for treatment of hematological malignancies. It has lowest nM IC50 values against TYK2, JAK1, JAK2, JAK3, FMS, and SYK.
|
Classification | Small molecule |
Drug class | tyrosine kinase inhibitors |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1 |
PDB | — |
CAS-ID | 1198300-79-6 |
RxCUI | — |
ChEMBL ID | CHEMBL4116008 |
ChEBI ID | — |
PubChem CID | 44595079 |
DrugBank | — |
UNII ID | D1LXQ45S1O (ChemIDplus, GSRS) |